Bio Plus Co., Ltd (KOSDAQ:099430)
South Korea
· Delayed Price · Currency is KRW 6,890.00
-150.00 (-2.13%)
Jun 27, 2025, 3:30 PM KST
Bio Plus Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Operating Revenue | 79,779 | 66,410 | 65,043 | 56,719 | 37,418 | 24,367 | Upgrade
|
| Other Revenue | -0 | -0 | - | - | - | - | Upgrade
|
| Revenue | 79,779 | 66,410 | 65,043 | 56,719 | 37,418 | 24,367 | Upgrade
|
| Revenue Growth (YoY) | 28.16% | 2.10% | 14.68% | 51.58% | 53.56% | 43.16% | Upgrade
|
| Cost of Revenue | 27,826 | 23,875 | 25,525 | 22,942 | 13,790 | 7,818 | Upgrade
|
| Gross Profit | 51,953 | 42,535 | 39,518 | 33,776 | 23,628 | 16,549 | Upgrade
|
| Selling, General & Admin | 18,408 | 14,172 | 8,170 | 6,534 | 4,339 | 2,719 | Upgrade
|
| Research & Development | 1,986 | 1,477 | 1,165 | 1,081 | 435.18 | 276.05 | Upgrade
|
| Other Operating Expenses | 247.61 | 203.06 | 155.02 | 59.11 | 11.46 | 8.28 | Upgrade
|
| Operating Expenses | 23,651 | 18,867 | 11,493 | 8,176 | 5,402 | 4,222 | Upgrade
|
| Operating Income | 28,302 | 23,667 | 28,026 | 25,600 | 18,226 | 12,327 | Upgrade
|
| Interest Expense | -284.36 | -263.43 | -60.28 | -13.3 | -521.47 | -58.16 | Upgrade
|
| Interest & Investment Income | 1,477 | 1,796 | 2,439 | 1,074 | 158.26 | 18.18 | Upgrade
|
| Earnings From Equity Investments | - | - | - | -311.08 | -327.99 | - | Upgrade
|
| Currency Exchange Gain (Loss) | 1,347 | 1,625 | 200.64 | 461.34 | 304.74 | -184.63 | Upgrade
|
| Other Non Operating Income (Expenses) | -8,006 | -8,037 | 2,103 | 129.56 | -2,107 | 34.9 | Upgrade
|
| EBT Excluding Unusual Items | 22,836 | 18,788 | 32,708 | 26,941 | 15,733 | 12,138 | Upgrade
|
| Gain (Loss) on Sale of Investments | 99.3 | 87.62 | 41.03 | 639.04 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 592.74 | 592.74 | -8.52 | -81.04 | - | -3.4 | Upgrade
|
| Asset Writedown | - | - | - | -28.02 | -1,565 | - | Upgrade
|
| Other Unusual Items | -1,804 | -1,804 | - | - | - | - | Upgrade
|
| Pretax Income | 21,724 | 17,664 | 32,740 | 27,471 | 14,168 | 12,134 | Upgrade
|
| Income Tax Expense | -1,658 | 153.09 | 5,318 | 6,763 | 3,495 | 2,431 | Upgrade
|
| Earnings From Continuing Operations | 23,382 | 17,510 | 27,422 | 20,708 | 10,673 | 9,703 | Upgrade
|
| Minority Interest in Earnings | -3,781 | -3,359 | -1,841 | 428.96 | 51.68 | - | Upgrade
|
| Net Income | 19,600 | 14,151 | 25,581 | 21,137 | 10,725 | 9,703 | Upgrade
|
| Net Income to Common | 19,600 | 14,151 | 25,581 | 21,137 | 10,725 | 9,703 | Upgrade
|
| Net Income Growth | -10.04% | -44.68% | 21.02% | 97.09% | 10.53% | 72.55% | Upgrade
|
| Shares Outstanding (Basic) | 57 | 57 | 58 | 57 | 52 | 50 | Upgrade
|
| Shares Outstanding (Diluted) | 63 | 60 | 61 | 57 | 52 | 50 | Upgrade
|
| Shares Change (YoY) | 5.72% | -0.28% | 5.64% | 10.68% | 3.82% | -2.75% | Upgrade
|
| EPS (Basic) | 344.20 | 249.20 | 444.85 | 371.84 | 207.02 | 194.39 | Upgrade
|
| EPS (Diluted) | 333.28 | 246.92 | 433.36 | 371.18 | 206.94 | 188.75 | Upgrade
|
| EPS Growth | -10.71% | -43.02% | 16.75% | 79.36% | 9.64% | 65.95% | Upgrade
|
| Free Cash Flow | -73,761 | -68,513 | -803.37 | 6,829 | -1,959 | 8,958 | Upgrade
|
| Free Cash Flow Per Share | -1168.41 | -1133.97 | -13.26 | 119.07 | -37.80 | 179.45 | Upgrade
|
| Dividend Per Share | 50.000 | 50.000 | 70.000 | 70.000 | - | - | Upgrade
|
| Dividend Growth | -28.57% | -28.57% | - | - | - | - | Upgrade
|
| Gross Margin | 65.12% | 64.05% | 60.76% | 59.55% | 63.15% | 67.92% | Upgrade
|
| Operating Margin | 35.48% | 35.64% | 43.09% | 45.14% | 48.71% | 50.59% | Upgrade
|
| Profit Margin | 24.57% | 21.31% | 39.33% | 37.27% | 28.66% | 39.82% | Upgrade
|
| Free Cash Flow Margin | -92.46% | -103.17% | -1.23% | 12.04% | -5.24% | 36.76% | Upgrade
|
| EBITDA | 31,647 | 26,937 | 30,516 | 27,487 | 19,524 | 13,338 | Upgrade
|
| EBITDA Margin | 39.67% | 40.56% | 46.92% | 48.46% | 52.18% | 54.74% | Upgrade
|
| D&A For EBITDA | 3,345 | 3,270 | 2,490 | 1,887 | 1,298 | 1,010 | Upgrade
|
| EBIT | 28,302 | 23,667 | 28,026 | 25,600 | 18,226 | 12,327 | Upgrade
|
| EBIT Margin | 35.48% | 35.64% | 43.09% | 45.14% | 48.71% | 50.59% | Upgrade
|
| Effective Tax Rate | - | 0.87% | 16.24% | 24.62% | 24.67% | 20.04% | Upgrade
|
| Advertising Expenses | - | 1,045 | 230.71 | 228.49 | 32.22 | 13.29 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.